Morgan Stanley set a CHF 260 price target on Roche (VTX:ROG) in a research report report published on Friday, November 17th. The brokerage currently has a neutral rating on the healthcare company’s stock.
Several other brokerages have also weighed in on ROG. set a CHF 203 target price on Roche and gave the stock a sell rating in a research report on Friday, October 20th. Berenberg Bank set a CHF 260 target price on Roche and gave the stock a neutral rating in a research report on Tuesday, October 24th. Goldman Sachs Group set a CHF 325 target price on Roche and gave the stock a buy rating in a research report on Monday, September 11th. Baader Bank set a CHF 231 target price on Roche and gave the stock a neutral rating in a research report on Tuesday, September 12th. Finally, UBS set a CHF 260 target price on Roche and gave the stock a neutral rating in a research report on Thursday, October 19th. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating and eight have assigned a buy rating to the stock. Roche currently has an average rating of Hold and a consensus target price of CHF 261.32.
Roche (ROG) traded up CHF 1.70 on Friday, hitting CHF 246.80. The stock had a trading volume of 1,240,000 shares, compared to its average volume of 1,720,000. Roche has a 52 week low of CHF 219.10 and a 52 week high of CHF 273.
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.